Cargando…
Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study
PURPOSE: The purpose of this study was to evaluate the diagnostic performance of novel ultrasound technology normalized local variance (NLV) and the standard deviation of NLV (NLV-SD) using different ROIs for hepatic steatosis in patients with metabolic-associated fatty liver disease (MAFLD) and to...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807465/ https://www.ncbi.nlm.nih.gov/pubmed/34958409 http://dx.doi.org/10.1007/s00261-021-03394-0 |
_version_ | 1784643673064996864 |
---|---|
author | Zhao, Yanan Zhang, Chao Xu, Shaoyan Zhang, Hui Wei, Shumei Huang, Pengfei Zhang, Lufei Wong, Yik Ning Xu, Wen Huang, Pintong |
author_facet | Zhao, Yanan Zhang, Chao Xu, Shaoyan Zhang, Hui Wei, Shumei Huang, Pengfei Zhang, Lufei Wong, Yik Ning Xu, Wen Huang, Pintong |
author_sort | Zhao, Yanan |
collection | PubMed |
description | PURPOSE: The purpose of this study was to evaluate the diagnostic performance of novel ultrasound technology normalized local variance (NLV) and the standard deviation of NLV (NLV-SD) using different ROIs for hepatic steatosis in patients with metabolic-associated fatty liver disease (MAFLD) and to identify the factors that influence the NLV value and NLV-SD value, using pathology results as the gold standard. METHODS: We prospectively enrolled 34 consecutive patients with suspected MAFLD who underwent percutaneous liver biopsy for evaluation of hepatic steatosis from June 2020 to December 2020. All patients underwent ultrasound and NLV examinations. NLV values and NLV-SD values were measured using different ROIs just before the liver biopsy procedure. RESULTS: The distribution of hepatic steatosis grade on histopathology was 4/19/6/5 for none (< 5%)/ mild (5–33%)/ moderate (> 33–66%)/ and severe steatosis (> 66%), respectively. The NLV value with 50-mm-diameter ROI and NLV-SD value with 50-mm-diameter ROI showed a significant negative correlation with hepatic steatosis (spearman correlation coefficient: − 0.449, p = 0.008; − 0.471, p = 0.005). The AUROC of NLV (50 mm) for the detection of mild, moderate, and severe hepatic steatosis was 0.875, 0.735, and 0.583, respectively. The AUROC of NLV-SD (50 mm) for the detection of mild, moderate, and severe hepatic steatosis was 0.900, 0.745, and 0.603, respectively. NLV (50 mm) values and NLV-SD (50 mm) values between two readers showed excellent repeatability and the intraclass correlation coefficient (ICC) was 0.930 (p < 0.001) and 0.899 (p < 0.001). Hepatic steatosis was the only determinant factor for NLV value and NLV-SD value (p = 0.012, p = 0.038). CONCLUSION: The NLV (50 mm) and NLV-SD (50 mm) provided good diagnostic performance in detecting the varying degrees of hepatic steatosis with great reproducibility. This study showed that the degree of steatosis was the only significant factor affecting the NLV value and NLV-SD value. |
format | Online Article Text |
id | pubmed-8807465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-88074652022-02-14 Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study Zhao, Yanan Zhang, Chao Xu, Shaoyan Zhang, Hui Wei, Shumei Huang, Pengfei Zhang, Lufei Wong, Yik Ning Xu, Wen Huang, Pintong Abdom Radiol (NY) Special Section: Diffuse Liver Disease PURPOSE: The purpose of this study was to evaluate the diagnostic performance of novel ultrasound technology normalized local variance (NLV) and the standard deviation of NLV (NLV-SD) using different ROIs for hepatic steatosis in patients with metabolic-associated fatty liver disease (MAFLD) and to identify the factors that influence the NLV value and NLV-SD value, using pathology results as the gold standard. METHODS: We prospectively enrolled 34 consecutive patients with suspected MAFLD who underwent percutaneous liver biopsy for evaluation of hepatic steatosis from June 2020 to December 2020. All patients underwent ultrasound and NLV examinations. NLV values and NLV-SD values were measured using different ROIs just before the liver biopsy procedure. RESULTS: The distribution of hepatic steatosis grade on histopathology was 4/19/6/5 for none (< 5%)/ mild (5–33%)/ moderate (> 33–66%)/ and severe steatosis (> 66%), respectively. The NLV value with 50-mm-diameter ROI and NLV-SD value with 50-mm-diameter ROI showed a significant negative correlation with hepatic steatosis (spearman correlation coefficient: − 0.449, p = 0.008; − 0.471, p = 0.005). The AUROC of NLV (50 mm) for the detection of mild, moderate, and severe hepatic steatosis was 0.875, 0.735, and 0.583, respectively. The AUROC of NLV-SD (50 mm) for the detection of mild, moderate, and severe hepatic steatosis was 0.900, 0.745, and 0.603, respectively. NLV (50 mm) values and NLV-SD (50 mm) values between two readers showed excellent repeatability and the intraclass correlation coefficient (ICC) was 0.930 (p < 0.001) and 0.899 (p < 0.001). Hepatic steatosis was the only determinant factor for NLV value and NLV-SD value (p = 0.012, p = 0.038). CONCLUSION: The NLV (50 mm) and NLV-SD (50 mm) provided good diagnostic performance in detecting the varying degrees of hepatic steatosis with great reproducibility. This study showed that the degree of steatosis was the only significant factor affecting the NLV value and NLV-SD value. Springer US 2021-12-27 2022 /pmc/articles/PMC8807465/ /pubmed/34958409 http://dx.doi.org/10.1007/s00261-021-03394-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Special Section: Diffuse Liver Disease Zhao, Yanan Zhang, Chao Xu, Shaoyan Zhang, Hui Wei, Shumei Huang, Pengfei Zhang, Lufei Wong, Yik Ning Xu, Wen Huang, Pintong Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study |
title | Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study |
title_full | Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study |
title_fullStr | Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study |
title_full_unstemmed | Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study |
title_short | Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study |
title_sort | quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (nlv) and its standard deviation with different rois in patients with metabolic-associated fatty liver disease: a pilot study |
topic | Special Section: Diffuse Liver Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807465/ https://www.ncbi.nlm.nih.gov/pubmed/34958409 http://dx.doi.org/10.1007/s00261-021-03394-0 |
work_keys_str_mv | AT zhaoyanan quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy AT zhangchao quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy AT xushaoyan quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy AT zhanghui quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy AT weishumei quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy AT huangpengfei quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy AT zhanglufei quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy AT wongyikning quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy AT xuwen quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy AT huangpintong quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy |